Thompson Davis & Co., Inc. Fulgent Genetics, Inc. Transaction History

Thompson Davis & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$77.3 - $105.0 $668,645 - $908,250	-8,650 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$3.29 - $5.12 $15,574 - $24,238	-4,734 Reduced 35.37%	8,650 $34,000
Q2 2018 Aug 03, 2018	SELL	$3.57 - $4.85 $8,739 - $11,872	-2,448 Reduced 15.46%	13,384 $55,000
Q1 2018 May 02, 2018	SELL	$3.67 - $5.19 $71,205 - $100,696	-19,402 Reduced 55.07%	15,832 $63,000
Q4 2017 Feb 05, 2018	BUY	$3.01 - $4.9 $106,054 - $172,646	35,234	35,234 $154,000

201

16.1M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $609M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Thompson Davis & Co., Inc. with notifications on news.